Seven-figure annual capital redirection demonstrated across physician-owned hospital and multi-physician group settings. These are results, not projections.
Client confidentiality means no named facilities. What it does not mean: no results. Here are the results.
"The question is not whether the model works. The question is how fast it scales."
MedMerge is currently coordinating independent groups across Louisiana, Oklahoma, Kansas, and Arizona. Structure is operational. Economics are demonstrable.
We do not ask physicians to trust projections. We show them the mechanics, the assumptions, and the demonstrated results. Every number is auditable.
| Assumption | Basis |
|---|---|
| Rate savings modeled at 25% | Coordinated group purchasing and captive structure. Actual savings vary by specialty and geography. |
| Captive surplus at 65% loss ratio | 80% of underwriting surplus returned to participating practices annually. |
| Float yield at 4.5% annually | Conservative. Based on 12 to 18 month reserve hold on encumbered capital. |
| 10-year projections | 3.5% annual compounding from reinvested surplus and float returns. |
| Rx reduction range | Demonstrated at 85% in pilot. Modeled conservatively at 40 to 60% for projections. |
The structure is auditable. The results are real. Client confidentiality is maintained. Named facilities available under NDA for institutional evaluation.